Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss the treatment choice between targeted therapy and immunotherapy in a patient with an EGFR Mutation and high PDL-1.
Lung Cancer
Lung Cancer
If you have been NEWLY DIAGNOSED START HERE
Filter By
Video Library
Cancer Journey:
Cancer Type:
Disease Learning:
Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss a frail patient with metastatic squamous NSCLC with low tumor PD-L1 expression, and the best treatment approach for this patient.
Cancer Journey:
Cancer Type:
Disease Learning:
Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss treating a patient with rapidly progressing lung adenocarcinoma and high tumor PD-L1 expression.
Cancer Journey:
Cancer Type:
Disease Learning:
, , , ,
The Global Resource for Advancing Cancer Education (GRACE), presents Molecular Diagnostic Testing and Next Generation Sequencing in Lung Cancer webinar series.
Cancer Journey:
Cancer Type:
Disease Learning:
Dr. Vamsidhar Velcheti with the Cleveland Clinic joined GRACE to discuss updates to our Lung Cancer Video Library. In this video, Dr. Velcheti discusses gilotrif/afatanib in squamous non small cell lung cancer.
Cancer Journey:
Cancer Type:
Disease Learning:
- 1 of 43
- View More
Articles
Please consider providing a tax-deductible gift this year. Your needed support, now more than ever, will ensure we continue to provide the best information about cancer arguably available anywhere, for patients and caregivers who so desperately need it.
Cancer Journey:
Cancer Type:
Disease Learning:
Watch the LIVE WEBCAST starting at 1 pm, Eastern, Saturday, November 18, 2017 in partnership with Georgetown University Hospital, GRACE presents: 2017 Advances in Immunotherapy: What Lung Cancer Patients Need to Know
Cancer Journey:
Cancer Type:
Disease Learning:
To many, the recent FDA approval of a combination of chemotherapy and concurrent immunotherapy for the vast majority of patients with advanced (metastatic) non-squamous non-small cell lung cancer (NSCLC) probably seems like a great idea.
Cancer Journey:
Cancer Type:
Disease Learning:
Dr. Jonathan Goldman joins GRACE to explain why carboplatin, pemetrexed and pembrolizumab has become his new go-to regimen for first-line non-squamous NSCLC treatment.
Cancer Journey:
Cancer Type:
Disease Learning:
Over the next few days, about 30,000 oncologists and other cancer care professionals, along with a growing number of patient advocates, are...
Cancer Journey:
Cancer Type:
Disease Learning:
- 1 of 245
- View More
Community Forum
Mother-in-Law was diagnosed with NSCLC and after a blood biopsy, doctor is recommending Osimertinib. I tried searching on the main page, but it wasn'...
Cancer Journey:
Cancer Type:
Disease Learning:
I have been in Xalkori for 2 months, A current CT scans shows the Stage 4 NSCLC (ROS1) is stable. An EKG shows a higher QTc (596) since the last EKG...
Cancer Journey:
Cancer Type:
Disease Learning:
Welcome to the new GRACE site! Here we hope to provide a new and friendly place for our community members, that goes beyond what our old forum did...
Cancer Journey:
Cancer Type:
Disease Learning:
I did 3 brain CT scans in the period of two months, the first two in the first weeks of July and the other on the last week of August. I know that...
Cancer Journey:
Cancer Type:
Disease Learning:
Wondering if anyone has info on compatibility of berberine with Tarceva. I called Genentech but they didn’t know. I am taking it because it has...
Cancer Journey:
Cancer Type:
Disease Learning:
- 1 of 6
- View More
